Jonathan Saltzman

Jonathan Saltzman is a member of the Globe’s Spotlight Team. He has more than two decades of journalism experience. He previously worked for WBUR and WRNI, the NPR stations in Massachusetts and Rhode Island. Before that, he was a reporter at the Providence Journal.

Latest stories

Sanofi expands footprint in Mass. with $11.6 billion purchase of Waltham-based Bioverativ

By , Globe Staff

Sanofi says the deal for the Biogen spinoff will boost its profile for fighting rare diseases.

Cambridge biotech startup names two top leaders

By , Globe Staff

Pandion Therapeutics has received $58 to work on treatments for immune system disorders.

Aveo CEO says biotech is rising from ashes of ‘an absolute catastrophe’

By , Globe Staff

Its kidney cancer drug — rejected by the FDA in 2013 — is on the market in Europe, and the Cambridge company is likely to seek US approval in 2019.

CRISPR Therapeutics CEO discounts concerns raised in an unpublished paper

By , Globe Staff

Samarth Kulkarni says the data are old, and not relevant to his company’s science.